跳转至内容

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

For important updates on recent policy changes, please click here for more details.

Merck
CN
所有图片(1)

主要文件

安全信息

1.04002

SAFC

Formaldehyde solution

37%, EMPROVE® EVOLVE

别名:

Formaline solution, Methanal solution, Methylaldehyde solution

登录查看公司和协议定价


About This Item

UNSPSC代码:
12352114

产品1.04002监管中,请联系销售询价或购买 联系客户支持

描述

stabilized with about 10% methanol Ph Eur,BP,USP

质量水平

产品线

EMPROVE® EVOLVE

表单

liquid

自燃温度

300 °C (Formaldehyde)

expl. lim.

7-73 % (v/v) Formaldehyde()

浓度

36.5-38% (iodometric)
37%

pH值(酸碱度)

2.8-4.0 (20 °C in H2O)

沸点

93-96 °C/1013 hPa

mp

<-15 °C

一般描述

我们提供一系列高品质的关键原材料及相关文档和专业知识,助您达成严格的监管要求。我们优质的SAFC®产品系列可经受严格的质控审查。

应用

甲醛可用于疫苗生产中的病毒灭活。

联系

替代品:1.04002.2507;1.04002.9187

法律信息

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

警示用语:

Danger

危险分类

Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - Carc. 1B - Eye Dam. 1 - Muta. 2 - Skin Corr. 1B - Skin Sens. 1 - STOT SE 1 - STOT SE 3

靶器官

Eyes,Central nervous system, Respiratory system

储存分类代码

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

WGK

WGK 3

闪点(°F)

143.6 °F - closed cup

闪点(°C)

62 °C - closed cup

法规信息

危险化学品
  • 技术规格说明书

  • 什么是Emprove®程序?

    Emprove® 程序是提供我们过滤器、一次性组件、制药原料和初始材料的全面而详尽文档的系统。

    Material Qualification Dossier

    免费 - 注册下载

    Operational Excellence Dossier

    可通过订阅或付费获得

    了解更多权益。 Emprove® 程序订阅所提供的好处
    为何这些文件不可用?
    Emprove®档案所包含的信息旨在为药品生产商的注册和风险评估活动提供支持,其中有一些机密信息。如果您想访问这些信息,请联系我们

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    João M Fernandes Neto et al.
    Nature communications, 11(1), 3157-3157 (2020-06-24)
    Resistance to targeted cancer drugs is thought to result from selective pressure exerted by a high drug dose. Partial inhibition of multiple components in the same oncogenic signalling pathway may add up to complete pathway inhibition, while decreasing the selective

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系客户支持